C. E. Barter

1.3k total citations
33 papers, 983 citations indexed

About

C. E. Barter is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, C. E. Barter has authored 33 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 6 papers in Oncology. Recurrent topics in C. E. Barter's work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory Support and Mechanisms (11 papers) and Asthma and respiratory diseases (6 papers). C. E. Barter is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory Support and Mechanisms (11 papers) and Asthma and respiratory diseases (6 papers). C. E. Barter collaborates with scholars based in Australia, United Kingdom and United States. C. E. Barter's co-authors include Alastair H. Campbell, Robert J. Pierce, P. Hugh‐Jones, Christine F. McDonald, Matthew T. Naughton, Trefor Morgan, Christopher Worsnop, Carolyn Blyth, Ian C. Marschner and Mark D. Lazarus and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

C. E. Barter

33 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. E. Barter Australia 16 683 380 123 104 99 33 983
T W Higenbottam United Kingdom 22 740 1.1× 412 1.1× 141 1.1× 90 0.9× 513 5.2× 53 1.4k
M Faller France 10 885 1.3× 304 0.8× 167 1.4× 18 0.2× 83 0.8× 14 1.1k
I. Court-Fortuné France 8 958 1.4× 389 1.0× 36 0.3× 26 0.3× 66 0.7× 18 1.2k
Dov Heimer Israel 18 305 0.4× 284 0.7× 57 0.5× 26 0.3× 113 1.1× 44 771
Cécile Chenivesse France 21 460 0.7× 319 0.8× 33 0.3× 116 1.1× 76 0.8× 79 1.1k
Orhan Çildağ Türkiye 13 309 0.5× 181 0.5× 43 0.3× 62 0.6× 39 0.4× 25 629
Marta Maskey‐Warzęchowska Poland 18 523 0.8× 354 0.9× 50 0.4× 21 0.2× 70 0.7× 70 733
Raquel Casitas Spain 15 509 0.7× 557 1.5× 218 1.8× 48 0.5× 40 0.4× 52 928
Morley Lertzman Canada 12 402 0.6× 126 0.3× 33 0.3× 122 1.2× 48 0.5× 23 662
Fisun Karadağ Türkiye 11 355 0.5× 178 0.5× 28 0.2× 68 0.7× 52 0.5× 28 657

Countries citing papers authored by C. E. Barter

Since Specialization
Citations

This map shows the geographic impact of C. E. Barter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. E. Barter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. E. Barter more than expected).

Fields of papers citing papers by C. E. Barter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. E. Barter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. E. Barter. The network helps show where C. E. Barter may publish in the future.

Co-authorship network of co-authors of C. E. Barter

This figure shows the co-authorship network connecting the top 25 collaborators of C. E. Barter. A scholar is included among the top collaborators of C. E. Barter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. E. Barter. C. E. Barter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Worsnop, Christopher, et al.. (1998). The Prevalence of Obstructive Sleep Apnea in Hypertensives. American Journal of Respiratory and Critical Care Medicine. 157(1). 111–115. 164 indexed citations
2.
Zalcberg, John, M.J. Millward, J. Bishop, et al.. (1998). Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.. Journal of Clinical Oncology. 16(5). 1948–1953. 81 indexed citations
3.
Kulinskaya, Elena, et al.. (1996). A methodology for measuring clinical outcomes in an acute care teaching hospital.. PubMed. 16(4). 203–14. 13 indexed citations
4.
McDonald, Christine F., Carolyn Blyth, Mark D. Lazarus, Ian C. Marschner, & C. E. Barter. (1995). Exertional Oxygen of Limited Benefit in Patients With Chronic Obstructive Pulmonary Disease and Mild Hypoxemia. American Journal of Respiratory and Critical Care Medicine. 152(5). 1616–1619. 114 indexed citations
5.
Zalcberg, John, James F. Bishop, Michael Millward, et al.. (1995). 1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S226–S226. 10 indexed citations
6.
Barter, C. E., et al.. (1992). Chronic persistent cough: use of ipratropium bromide in undiagnosed cases following upper respiratory tract infection. Respiratory Medicine. 86(5). 425–429. 47 indexed citations
7.
Allen, Richard K., Robert J. Pierce, & C. E. Barter. (1992). Angiotensin-converting enzyme in bronchoalveolar lavage fluid in sarcoidosis.. PubMed. 9(1). 54–9. 7 indexed citations
8.
Barter, C. E., et al.. (1992). An evaluation of three elements of pulmonary rehabilitation. Australian Journal of Physiotherapy. 38(3). 189–193. 8 indexed citations
9.
Flynn, Michael G., et al.. (1989). Threshold Pressure Training, Breathing Pattern, and Exercise Performance in Chronic Airflow Obstruction. CHEST Journal. 95(3). 535–540. 38 indexed citations
10.
Pierce, Robert J., et al.. (1986). Lobar occlusion in the preoperative assessment of patients with lung cancer. British Journal of Diseases of the Chest. 80(1). 27–36. 8 indexed citations
11.
Anavekar, S. N., C. E. Barter, W. R. Adam, & A. E. Doyle. (1982). A Double-Blind Comparison of Verapamil and Labetalol in Hypertensive Patients with Coexisting Chronic Obstructive Airways Disease. Journal of Cardiovascular Pharmacology. 4(Supplement 3). S378–S378. 25 indexed citations
12.
Hugh‐Jones, P., et al.. (1978). Dead space and tidal volume of the giraffe compared with some other mammals. Respiration Physiology. 35(1). 53–58. 23 indexed citations
13.
Hardy, K. J., et al.. (1977). An Evaluation of Preoperative Methods of Preventing Postoperative Pulmonary Complications. Anaesthesia and Intensive Care. 5(1). 56–59. 9 indexed citations
14.
Barter, C. E. & Alastair H. Campbell. (1976). Relationship of constitutional factors and cigarette smoking to decrease in 1-second forced expiratory volume.. PubMed. 113(3). 305–14. 117 indexed citations
15.
16.
Barter, C. E., Alastair H. Campbell, & M. K. Tandon. (1974). Factors Affecting the Decline of FEV1 in Chronic Bronchitis. Australian and New Zealand Journal of Medicine. 4(4). 339–345. 19 indexed citations
17.
Barter, C. E., P. Hugh‐Jones, J. W. Laws, & W. A. Crosbie. (1973). Radiology compared with xenon--133 scanning and bronchoscopic lobar sampling as methods for assessing regional lung function in patients with emphysema. Thorax. 28(1). 29–40. 2 indexed citations
18.
Pride, N. B., C. E. Barter, & P. Hugh‐Jones. (1973). The ventilation of bullae and the effect of their removal on thoracic gas volumes and tests of over-all pulmonary function.. PubMed. 107(1). 83–98. 37 indexed citations
19.
Cook, P.J.L., et al.. (1971). Pulmonary Emphysema and α 1 -Antitrypsin Deficiency. BMJ. 1(5751). 689–694. 74 indexed citations
20.
HUTCHISON, D, P.J.L. Cook, & C. E. Barter. (1970). Pulmonary Emphysema and Alpha1-Antitrypsin Deficiency. Clinical Science. 38(3). 19P–19P. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T W Higenbottam Breakdown of academic impact, for papers by M Faller Breakdown of academic impact, for papers by I. Court-Fortuné Breakdown of academic impact, for papers by Dov Heimer Breakdown of academic impact, for papers by Cécile Chenivesse Breakdown of academic impact, for papers by Orhan Çildağ Breakdown of academic impact, for papers by Marta Maskey‐Warzęchowska Breakdown of academic impact, for papers by Raquel Casitas Breakdown of academic impact, for papers by Morley Lertzman Breakdown of academic impact, for papers by Fisun Karadağ
Rankless by CCL
2026